Medicare Enrolled

Dr. Daymi Cowgill, MD

Dermatology · Plant City, FL
1509 W REYNOLDS ST, Plant City, FL 33563
8137046905
Registered in NPPES since 2018
NPI: 1437634144 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cowgill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cowgill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cowgill

Dr. Daymi Cowgill is a dermatology specialist in Plant City, FL, with 7 years of NPI registration.

Between the years covered by Open Payments, Dr. Cowgill received a total of $1,421 from 24 pharmaceutical and/or device companies across 69 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cowgill is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years of NPI registration $1,421 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 174307 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$1,421
Total received (2019-2024)
Avg $284/year across 5 years
Top 22% in FL for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
69
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$52
2023
$146
2022
$192
2021
$899
2019
$132

Payments by company (2024)

Lilly USA, LLC
$34
AstraZeneca Pharmaceuticals LP
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2019-2024) ›
AbbVie Inc.
$273
Lilly USA, LLC
$252
AstraZeneca Pharmaceuticals LP
$134
ABBVIE INC.
$82
Novartis Pharmaceuticals Corporation
$75
Janssen Pharmaceuticals, Inc
$70
DePuy Synthes Sales Inc.
$60
Emergent BioSolutions Inc.
$57
Amgen Inc.
$50
DEXCOM, INC.
$46
Xeris Pharmaceuticals, Inc.
$40
Esperion Therapeutics, Inc.
$37
Merck Sharp & Dohme Corporation
$36
Novo Nordisk Inc
$35
PFIZER INC.
$25
Dexcom, Inc.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Astellas Pharma US Inc
$19
Biohaven Pharmaceuticals, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
GlaxoSmithKline, LLC.
$16
EVOKE PHARMA, INC.
$14
Smith+Nephew, Inc.
$14
SCILEX PHARMACEUTICALS INC.
$12
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
Aimovig · BELSOMRA · BREZTRI · COLLAGENASE SANTYL · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EXPEDIUM · FARXIGA · FASENRA · GIMOTI · GVOKE PFS · INVOKANA · JARDIANCE · Kerendia · MOUNJARO · MYRBETRIQ · NEXLETOL · NEXLIZET · NURTEC ODT · Narcan · Ozempic · PREMARIN · Rybelsus · SYMBICORT · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · XIFAXAN · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Plant City?
Compare dermatologists in the Plant City area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
186
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
SOUTH FLORIDA BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cowgill is a dermatology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Cowgill receive payments from pharmaceutical companies?
Yes. Dr. Cowgill received a total of $1,421 from 24 companies across 69 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Cowgill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →